From Medscape Cardiology

Medscape Medical News from the:

American College of Cardiology (ACC) 59th Annual Scientific Session

March 14 - 16, 2010; Atlanta, Georgia

This coverage is not sanctioned by, nor a part of, the American College of Cardiology.


ACC 2010: Top Research Highlights
The focus of the American College of Cardiology (ACC) 59th Annual Scientific Sessions was patient-centered care, with the aim of helping healthcare providers take home information and immediately put it into practice.

Conference News


The materials presented here do not reflect the views of WebMD, LLC. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or employing any therapies described in this article.

The materials presented here were prepared by independent authors under the editorial supervision of WebMD, LLC, and do not represent a publication of the American College of Cardiology. These materials are not sanctioned by the American College of Cardiology and do not constitute an official part of the conference.

Medscape Cardiology©  WebMD, LLC

Expert Blog

ACC 2010 – What Makes it Tick
Larry Phillips, MD

Expert Video Commentary

Dr. Melissa Walton-Shirley covers highlights of the 2010 American College of Cardiology meeting as they unfold. Although the focus of the meeting is patient-centered care, researchers also present important -- and sometimes unexpected -- findings from major studies.

Expert Video Blog

Dr. Ileana Piña, Professor of Medicine at Case Western Reserve University, reports on ACC 2010 from her own perspective as a leader in heart failure and a champion of reducing health disparities.

Should You Push Your Patients With Diabetes to Lower Blood Pressure Below 120?
Henry Black, MD, talked to William Cushing, MD, principal investigator on the ACCORD trial, about whether intensive lowering of blood pressure in patients with diabetes was beneficial.